Showing results (51-60 of 83) with videos related to
Sort By:
Pageof 9
Diabetes & Metabolism Journal|January 10, 2014
Prevalence and Management of Dyslipidemia in Korea: Korea National Health and Nutrition Examination Survey during 1998 to 2010Eun Roh, Seung-Hyun Ko, Hyuk-Sang Kwon, et al.Diabetes, Obesity & Metabolism|September 16, 2025
Efficacy and safety in tirzepatide-treated Korean adults with type 2 diabetes-A post hoc analysis of SURPASS-AP-combo and SURPASS-3Byung Wan Lee, Chang Beom Lee, Soo Lim, et al.Nature Neuroscience|June 20, 2006
Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasisMin-Seon Kim, Youngmi K Pak, Pil-Geum Jang, et al.Diabetes & Metabolism Journal|December 17, 2025
Efficacy and Safety of HD-6277, a Novel G Protein-Coupled Receptor 40 Agonist, in Individuals with Type 2 Diabetes Mellitus: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 2 Clinical TrialYong-Ho Lee, Kyung Wan Min, Jun Hwa Hong, et al.Biochemical and Biophysical Research Communications|December 21, 2005
AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1Woo Je Lee, Mina Kim, Hye-Sun Park, et al.Diabetes & Metabolism Journal|March 15, 2014
Higher prevalence and awareness, but lower control rate of hypertension in patients with diabetes than general population: the fifth korean national health and nutrition examination survey in 2011Seung-Hyun Ko, Hyuk-Sang Kwon, Dae Jung Kim, et al.Diabetes & Metabolism Journal|July 9, 2014
Current status of glycemic control of patients with diabetes in Korea: the fifth Korea national health and nutrition examination surveyJa Young Jeon, Dae Jung Kim, Seung-Hyun Ko, et al.Diabetes & Metabolism Journal|October 28, 2025
Efficacy and Safety of High-Dose Pioglitazone as Add-on Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: Double-Blind, Randomized, Placebo-Controlled TrialJun Hwa Hong, Kyung Ah Han, You-Cheol Hwang, et al.Journal of Diabetes Investigation|July 2, 2022
Analysis of clinical phenotypes of neuropathic symptoms in patients with type 2 diabetes: A multicenter studyYu Ji Kim, Jeong Min Lee, Chang Won Lee, et al.Clinical Therapeutics|May 7, 2018
Comparison of Adherence to Glimepiride/Metformin Sustained Release Once-daily Versus Glimepiride/Metformin Immediate Release BID Fixed-combination Therapy Using the Medication Event Monitoring System in Patients With Type 2 DiabetesJong-Dai Kim, Cheol-Young Park, Bong-Yun Cha, et al.Pageof 9